Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 3Recruiting 2Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lymphoma, Large B-Cell, Diffuse 24Lymphoma 11Lymphoma, Non-Hodgkin 9Prostatic Neoplasms 8Lymphoma, T-Cell, Peripheral 8Lymphoma, Follicular 7Leukemia 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Multiple Myeloma 5Neoplasms, Plasma Cell 4Lymphoma, Mantle-Cell 4Hodgkin Disease 3Burkitt Lymphoma 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Myasthenia Gravis 2Lymphoma, Large-Cell, Immunoblastic 2Immunoblastic Lymphadenopathy 2Subcutaneous panniculitis-like T-cell lymphoma 1Spinal Cord Neoplasms 1Recurrence 1Prostatic Neoplasms, Castration-Resistant 1Plasmablastic Lymphoma 1Pituitary Neoplasms 1Neoplasms, Experimental 1Neoplasms 1Neoplasm Metastasis 1Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel 1Neoadjuvant Therapy 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1

Interventions

Abiraterone Acetate 2enzalutamide 1cabazitaxel 1abiraterone 1Prednisone 1Photons 1Exome Sequencing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Prostatic Neoplasms, Castration-Resistant × Prednisone × Clear all
NCT05156450 2021-12-14

TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer

West China Hospital

Phase 2 Unknown
30 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡